How have GERN and JBIO total returns compared?

Over the past 5 years, GERN delivered -1.87% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.

Geron Corporation (GERN) vs Jade Biosciences, Inc. (JBIO)

A side-by-side comparison of Geron Corporation and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GERN

Geron Corporation

$789M

$1.23HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

JBIO

Jade Biosciences, Inc.

$825M

$13.56HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — GERN vs JBIO

growth of $100 · dividends reinvested · last 5y

GERN -14.2% (-3.0%/yr)JBIO -97.8% (-53.5%/yr)GERN compounded faster over this window

Log scale — wide-divergence pair

GERN JBIO

GERN vs JBIO: by the numbers

•JBIO is the larger company ($825M vs $789M market cap).
•Both run net losses; JBIO's is the smaller (0.00% vs -34.17% net margin).

Metrics side by side

Valuation

Metric	GERN	JBIO
P/S ratio	3.86	N/A
P/B ratio	3.61	1.88

Profitability

Metric	GERN	JBIO
Gross margin	97.42%	0.00%
Operating margin	-29.28%	0.00%
Net margin	-34.17%	0.00%
ROE	-31.97%	-34.83%
ROIC	-8.34%	-37.39%

Growth (annualized)

Metric	GERN	JBIO
Revenue CAGR (5Y)	247.85%	N/A
Total return CAGR (5Y)	-1.87%	-52.65%

Frequently asked

How have GERN and JBIO total returns compared?: Over the past 5 years, GERN delivered -1.87% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GERN analysis Full JBIO analysis Interactive comparison tool

Dig into the metrics

Geron ROE Jade Biosciences ROE Geron operating margin Jade Biosciences operating margin Geron revenue growth Jade Biosciences revenue growth Geron free cash flow Jade Biosciences free cash flow

Geron & Jade Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.